Adolescent Vaccines: Latest Recommendations,Addressing Barriers,and Improving Vaccine Rates

Abstract

The Advisory Committee on Immunization Practices recommends that the Tdap, HPV, and meningitis vaccines be administered to youth beginning between the ages of 11 and 12. The school nurse, knowledgeable about vaccine schedules and the rationale for the schedules, is in a unique position to advocate for all adolescent vaccines and their timely administration through addressing parent-guardian concerns and supporting other healthcare providers in completing the adolescent vaccines. This article reviews current recommendations for adolescent vaccinations and the actions needed to improve vaccination rates with a focus on Human Papillomavirus vaccine, the vaccine with the lowest completion rates among this age group. Additionally, school nurses are introduced to Middle School Health Starts Here, a program for school nurses designed to address the whole child as students progress from 5th grade to middle school. Public policy issues including school mandates, along with possible barriers to vaccine completion in adolescents, are discussed.

Keywords

adolescent vaccines school nurse interventions HPV Tdap meningococcal

Get full access to this article

View all access options for this article.

References

American Academy of Pediatrics. (2017). American Academy of Pediatrics emphasizes safety and importance of vaccines. Retrieved from https://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/American-Academy-of-Pediatrics-Emphasizes-Safety-and-Importance-of-Vaccines.aspx

American Cancer Society. (2016). Middle school health starts here. HPV Roundtable. Retrieved from http://www.middleschoolhealth.org

Bernstein

H. H.

Bocchini

J. J.

; AAP Committee on Infectious Diseases. (2017). Practical approaches to optimize adolescent immunization. Pediatrics, 139(3), 1-14. e20154187

Centers for Disease Control and Prevention. (2012). If you choose not to immunize. Retrieved from https://www.cdc.gov/vaccines/hcp/conversations/downloads/not-vacc-risks-color-office.pdf

Centers for Disease Control and Prevention. (2014). Epidemiology of serogroup B meningococcal disease. Advisory Committee on Immunization Practices. October 30, 2014. Retrieved from www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-2014-10.pdf

Centers for Disease Control and Prevention. (2015). Vaccine information statements Tdap. Retrieved from https://www.cdc.gov/vaccines/hcp/vis/vis-statements/tdap.pdf

Centers for Disease Control and Prevention. (2016a). Vaccines and immunizations glossary. Retrieved from https://www.cdc.gov/vaccines/terms/glossary.html

Centers for Disease Control and Prevention. (2016b). Vaccine information statements HPV. Retrieved from https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv.pdf

Centers for Disease Control and Prevention. (2016c). Tdap pregnant women. Retrieved from https://www.cdc.gov/vaccines/pregnancy/hcp/guidelines.html#tdap

10.

Centers for Disease Control and Prevention. (2016d). Vaccine information statements Men A C W Y. Retrieved from https://www.cdc.gov/vaccines/hcp/vis/vis-statements/mening.pdf

11.

Centers for Disease Control and Prevention. (2016e). Vaccine information statements Men B. Retrieved from https://www.cdc.gov/vaccines/hcp/vis/vis-statements/mening-serogroup.html

12.

Centers for Disease Control and Prevention. (2017a). For healthcare providers/clinicians: you are the key. Retrieved from https://www.cdc.gov/vaccines/who/teens/for-hcp.html

13.

Centers for Disease Control and Prevention. (2017b). Immunization schedule. Retrieved from https://www.cdc.gov/vaccines/schedules/downloads/teen/parent-version-schedule-7-18yrs.pdf

14.

Centers for Disease Control and Prevention. (2017c). Making the vaccine decision. Retrieved from https://www.cdc.gov/vaccines/parents/vaccine-decision/index.html?s_cid=bb-vaccines-Child-HP04-NCIRD

15.

Clark

Bobo

(2012). CDC update on pertussis surveillance and Tdap vaccine recommendations. NASN School Nurse, 27(6), 297-300.

16.

Darden

P. M.

Thompson

D. M.

Roberts

J. R.

Hale

J. J.

Pope

Naifeh

Jacobsen

R. M.

(2013). Reasons for not vaccinating adolescents: national immunization survey of teens, 2008-2010. Pediatrics, 131(4), 645-651. doi:10.1542/peds.2012-2384

17.

Kirsch

E. A.

Barton

Kitchen

Giroir

B. P.

(1996). Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatric Infectious Disease Journal, 15, 967-979.

18.

Luckett

Feldman

(2015). Impact of 2-,4-, and 9-valent HPV vaccines on morbidity and mortality from cervical cancer. Human Vaccines & Immunotherapeutics, 12(6), 1332-1342. http://dx.doi.org/10.1080/21645515.2015.1108500

19.

Meites

Kempe

Markowitz

L. E.

(2016). Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report, 65, 1405-1408. http://dx.doi.org/10.15585/mmwr.mm6549a5

20.

Moss

J. L.

Reiter

P. L.

Young

K. T.

(2016). School entry requirements and coverage of nontargeted adolescent vaccines. Pediatrics, 138(6), 1-10. doi:10.1542/peds.2016-1414

21.

NASN. (2015). Immunizations (position statement). Retrieved from https://schoolnursenet.nasn.org/blogs/nasn-profile/2017/03/13/immunizations-ps

22.

Opel

D. J.

Heritage

Taylor

J. A.

Mangione-Smith

Salas

H. S.

Devere

. . . Robinson

J. D.

(2013). The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics, 132(6), 1037-1046. PMID:24190677. http://dx.doi.org/10.1542/peds.2013-2037

23.

Palfrey

(2016). New initiatives to improve HPV vaccination rates. Human Vaccines & Immunotherapeutics, 12(6), 1594-1598. http://dx.doi.org/10.1080/21645515.2016.1145316

24.

Perkins

R. B.

(2016). HPV vaccinations: clinical potential, implementation challenges, and future directions. Human Vaccines & Immunotherapeutics, 12(6), 1327-1331. http://dx.doi.org/10.1080/21645515.2016.1177680.

25.

Perkins

R. B.

(2015). Why don’t adolescents finish the HPV vaccine series? A qualitative study of parents and providers. Human Vaccines & Immunotherapeutics, 12(6), 1528-1535. http://dx.doi.org/10.1080/21645515.2015.1118594

26.

Perkins

R. B.

Clark

J. A.

(2013). Providers’ perceptions of parental concerns about HPV vaccination. Journal of Health Care for Poor and Underserved, 24, 828-839. PMID:23728048. http://dx.doi.org/10.1353/hpu.2013.0080

27.

Reagan-Steiner

Yankey

Jeyarajah

(2015). National, regional, state and selected local area vaccination coverage among adolescents aged 13-17 years, United States, 2014. MMWR Morb Mortal Wkly Rep 64: 784–792. https://stacks.cdc.gov/view/cdc/32465

28.

Swallow

Roberts

J. C.

(2016). An evidenced-based project demonstrating increased school immunization compliance following a school nurse-initiated vaccine compliance strategy. The Journal of School Nursing, 32(6), 385-389.